Stockhead TV
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Telix Pharmaceuticals.
RELATED STOCKHEAD STORIES
Health & Biotech
The chances of Phase 3 success, and the ASX health stocks that are close to a home run
Health & Biotech
ScoPo’s Powerplays: ASX health stocks sprout 4.6%, as Volpara soars on first positive cash flow
News
ASX Large Caps: Shares lack direction as earnings weigh; Amazon named world’s most valuable brand
News
ASX Small Caps Lunch Wrap: Who else has been getting a little carried away recently?
News
ASX Earnings Wrap: Redbubble sinks 11pc on outlook; QuickFee and Volpara gain momentum
Health & Biotech
ScoPo’s Powerplays: Volpara leads a minor ASX small cap health sector renaissance
News
CLOSING BELL: ‘Burning cash, with a hint of Musk’ revealed as Tesla’s latest new car smell
News
ASX Large Caps: Local shares buck Wall Street as buyers come back to the market
News
ASX Large Caps: ASX down almost 1% to 20-day low, energy stocks lead losses
Health & Biotech
Check Up: The TGA is 100pc cool with the world’s first faecal transplant, oral delivery being studied
Health & Biotech
ASX Biotech Stocks: Medibank says nope to paying ransom for data theft
Health & Biotech
Check Up: These 4 ASX healthcare stocks come with Strong Buy recommendations
News
ASX Large Caps: Coal stocks gain; Novonix in hot water over disclosure
News
ASX Quarterlies: The BNPL turnaround we’ve been waiting for? Zip delivers, share price up 5pc
Health & Biotech
Phase III Trials: These ASX health stocks are on the pivotal home stretch
News
ASX Large Caps: More volatility as shares swing back to upside; RBA says rates will keep rising
News